These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34638963)

  • 1. The FMN "140s Loop" of Cytochrome P450 Reductase Controls Electron Transfer to Cytochrome P450.
    Rwere F; Im S; Waskell L
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutants of Cytochrome P450 Reductase Lacking Either Gly-141 or Gly-143 Destabilize Its FMN Semiquinone.
    Rwere F; Xia C; Im S; Haque MM; Stuehr DJ; Waskell L; Kim JJ
    J Biol Chem; 2016 Jul; 291(28):14639-61. PubMed ID: 27189945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A flexible linker of 8-amino acids between the membrane binding segment and the FMN domain of cytochrome P450 reductase is necessary for optimal activity.
    Rwere F; Cartee NMP; Yang Y; Waskell L
    J Inorg Biochem; 2024 Oct; 259():112667. PubMed ID: 39032346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome b5 inhibits electron transfer from NADPH-cytochrome P450 reductase to ferric cytochrome P450 2B4.
    Zhang H; Hamdane D; Im SC; Waskell L
    J Biol Chem; 2008 Feb; 283(9):5217-25. PubMed ID: 18086668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the rate of reduction of oxyferrous cytochrome P450 2B4 by 5-deazariboflavin adenine dinucleotide T491V cytochrome P450 reductase.
    Zhang H; Gruenke L; Arscott D; Shen A; Kasper C; Harris DL; Glavanovich M; Johnson R; Waskell L
    Biochemistry; 2003 Oct; 42(40):11594-603. PubMed ID: 14529269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protonation of the Hydroperoxo Intermediate of Cytochrome P450 2B4 Is Slower in the Presence of Cytochrome P450 Reductase Than in the Presence of Cytochrome b5.
    Pearl NM; Wilcoxen J; Im S; Kunz R; Darty J; Britt RD; Ragsdale SW; Waskell L
    Biochemistry; 2016 Nov; 55(47):6558-6567. PubMed ID: 27797496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the Insertion of a Glycine Residue into the Loop Spanning Residues 536-541 on the Semiquinone State and Redox Properties of the Flavin Mononucleotide-Binding Domain of Flavocytochrome P450BM-3 from Bacillus megaterium.
    Chen HC; Swenson RP
    Biochemistry; 2008 Dec; 47(52):13788-99. PubMed ID: 19055322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of the re-face loop spanning residues 536-541 and its interactions with the cofactor in the flavin mononucleotide-binding domain of flavocytochrome P450 from Bacillus megaterium.
    Kasim M; Chen HC; Swenson RP
    Biochemistry; 2009 Jun; 48(23):5131-41. PubMed ID: 19432415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electron transfer by human wild-type and A287P mutant P450 oxidoreductase assessed by transient kinetics: functional basis of P450 oxidoreductase deficiency.
    Jin Y; Chen M; Penning TM; Miller WL
    Biochem J; 2015 May; 468(1):25-31. PubMed ID: 25728647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and Kinetic Studies of Asp632 Mutants and Fully Reduced NADPH-Cytochrome P450 Oxidoreductase Define the Role of Asp632 Loop Dynamics in the Control of NADPH Binding and Hydride Transfer.
    Xia C; Rwere F; Im S; Shen AL; Waskell L; Kim JP
    Biochemistry; 2018 Feb; 57(6):945-962. PubMed ID: 29308883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic and structural characterization of the interaction between the FMN binding domain of cytochrome P450 reductase and cytochrome c.
    Huang R; Zhang M; Rwere F; Waskell L; Ramamoorthy A
    J Biol Chem; 2015 Feb; 290(8):4843-4855. PubMed ID: 25512382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational changes of NADPH-cytochrome P450 oxidoreductase are essential for catalysis and cofactor binding.
    Xia C; Hamdane D; Shen AL; Choi V; Kasper CB; Pearl NM; Zhang H; Im SC; Waskell L; Kim JJ
    J Biol Chem; 2011 May; 286(18):16246-60. PubMed ID: 21345800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP2C9 protein interactions with cytochrome b(5): effects on the coupling of catalysis.
    Locuson CW; Wienkers LC; Jones JP; Tracy TS
    Drug Metab Dispos; 2007 Jul; 35(7):1174-81. PubMed ID: 17446262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional characterization of a cytochrome P450 2B4 F429H mutant with an axial thiolate-histidine hydrogen bond.
    Yang Y; Zhang H; Usharani D; Bu W; Im S; Tarasev M; Rwere F; Pearl NM; Meagher J; Sun C; Stuckey J; Shaik S; Waskell L
    Biochemistry; 2014 Aug; 53(31):5080-91. PubMed ID: 25029089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and function of an NADPH-cytochrome P450 oxidoreductase in an open conformation capable of reducing cytochrome P450.
    Hamdane D; Xia C; Im SC; Zhang H; Kim JJ; Waskell L
    J Biol Chem; 2009 Apr; 284(17):11374-84. PubMed ID: 19171935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of a 5'-deazaFAD T491V NADPH-cytochrome P450 reductase.
    Zhang H; Gruenke L; Saribas AS; Im SC; Shen AL; Kasper CB; Waskell L
    Biochemistry; 2003 Jun; 42(22):6804-13. PubMed ID: 12779335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the length and sequence of the linker domain of cytochrome b5 in stimulating cytochrome P450 2B4 catalysis.
    Clarke TA; Im SC; Bidwai A; Waskell L
    J Biol Chem; 2004 Aug; 279(35):36809-18. PubMed ID: 15194706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
    Roitel O; Scrutton NS; Munro AW
    Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of ferric cytochrome P450 reduction by NADPH-cytochrome P450 reductase: rapid reduction in the absence of substrate and variations among cytochrome P450 systems.
    Guengerich FP; Johnson WW
    Biochemistry; 1997 Dec; 36(48):14741-50. PubMed ID: 9398194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cytochrome P450 oxidoreductase deficiency caused by the Y181D mutation: molecular consequences and rescue of defect.
    Marohnic CC; Panda SP; McCammon K; Rueff J; Masters BS; Kranendonk M
    Drug Metab Dispos; 2010 Feb; 38(2):332-40. PubMed ID: 19884324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.